Why the study?
Aggressive cardiovascular risk factor modification does not eliminate heart failure risk in type 2 diabetes, indicating other factors contribute to the pathogenesis and reduced exercise tolerance.
This review highlights that reduced exercise tolerance in T2D is an early sign of heart failure and explores its cardiac and extra-cardiac determinants.
May prompt exercise tolerance monitoring in T2D for early HF signals; leaves open prospective validation of determinants.
The global burden of heart failure (HF) is on the rise owing to an increasing incidence of lifestyle related diseases, predominantly type 2 diabetes mellitus (T2D). Diabetes is an independent risk factor for cardiovascular disease, and up to 75% of those with T2D develop HF in their lifetime. T2D leads to pathological alterations within the cardiovascular system, which can progress insidiously and asymptomatically in the absence of conventional risk factors. Reduced exercise tolerance is consistently reported, even in otherwise asymptomatic individuals with T2D, and is the first sign of a failing heart. Because aggressive modification of cardiovascular risk factors does not eliminate the risk of HF in T2D, it is likely that other factors play a role in the pathogenesis of HF. Early identification of individuals at risk of HF is advantageous, as it allows for modification of the reversible risk factors and early initiation of treatment with the aim of improving clinical outcomes. In this review, cardiac and extra-cardiac contributors to reduced exercise tolerance in people with T2D are explored.
No takes yet. Share an insight, caveat, or question.
Joanna M Bilak (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: